Healthcare - Biotechnology - NASDAQ - US
$ 2.47
-4.26 %
$ 51 M
Market Cap
-0.82
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
21.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Protara Therapeutics, Inc.
TARA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TARA
EBIT FORECAST
EBIT Forecast Chart TARA
NET INCOME FORECAST
Net Income Chart TARA